Germany
Japan
United Kingdom
China
Mouse Monoclonal ApoE4 Antibody (4E4)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Antibodies
View as table Download
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 3C2-4
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 3G11-14
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 4A5-19
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 5F4-15
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 6F5-23
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 6H8-22
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 9G5-20
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 12G4-15
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 15C4-8
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 16F12-11
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Mouse Monoclonal anti-Syk Antibody
| Applications | WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Mouse Monoclonal alpha Tubulin Antibody (DM1A) - Microtubule Marker
| Applications | IHC, WB |
| Reactivities | Bovine, Chicken, Guinea Pig, Human, Mouse, Porcine, Rat, Xenopus |
| Conjugation | Unconjugated |
MCP-2 / CCL8 Mouse Monoclonal Antibody
| Applications | IHC |
| Reactivities | Human |
Mouse monoclonal anti-ATP1A1(NaK ATPase) antibody, clone 464.6, Loading control
| Applications | FC, IHC, WB |
| Reactivities | Canine, Human, Mouse, Porcine, Primate, Rabbit, Rat, Sheep, Xenopus |
| Conjugation | Unconjugated |
CRISPR/Cas9 - HRP monoclonal antibody
| Applications | WB |
| Reactivities | Streptococcus Pyogenes |
Mouse Monoclonal NAK Antibody (108A429)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat, Bovine, Canine |
| Conjugation | Unconjugated |
TA336453 is a replacement of AM08296PU-N.
USD 424.00
In Stock
Mouse Monoclonal Nestin Antibody (10C2)
| Applications | FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
TA309763 is a replacement of TA320427.
OSTF1 / OSF Mouse Monoclonal (AT2F11) Antibody
| Applications | IHC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Mouse monoclonal Anti-Neutrophil elastase Clone NP57
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 457.00
5 Days
Active filters
Isotypes
- IgG1, kappa
Filter by
Target Symbol
- ERBB2 (43)
- EGFR (8)
- IL2RA (7)
- CD276 (6)
- LAG3 (6)
- CD19 (5)
- MYC (5)
- CD28 (4)
- CD4 (4)
- CD40LG (4)
- F (4)
- TP73 (4)
- VEGFA (4)
- AKT1 (3)
- APOA5 (3)
- BAX (3)
- CD38 (3)
- CD3E (3)
- CD63 (3)
- CD68 (3)
- CD81 (3)
- DNMT1 (3)
- EPCAM (3)
- FCGR2B (3)
- FITC (3)
- HIS (3)
- MMP2 (3)
- MMP9 (3)
- MS4A1 (3)
- MUC5B (3)
- NEFH (3)
- NFKB1 (3)
- NFKBIA (3)
- PTPRC (3)
- TAL1 (3)
- TIMP1 (3)
- TNF (3)
- V5 (3)
- WT1 (3)
- ACPP (2)
- ADRB2 (2)
- APOE (2)
- BCL2 (2)
- BIRC5 (2)
- CAS9 (2)
- CCR5 (2)
- CD1A (2)
- CD22 (2)
- CD37 (2)
- CD40 (2)
- CD52 (2)
- CD74 (2)
- CD8A (2)
- CEA (2)
- CR1 (2)
- CYP2A6 (2)
- DNAJA2 (2)
- DNMT3A (2)
- ELANE (2)
- ENO2 (2)
- F7 (2)
- F8 (2)
- FANCM (2)
- FCER1G (2)
- FN1 (2)
- HIP1 (2)
- IL18 (2)
- INSR (2)
- ITGA2B (2)
- ITGA4 (2)
- ITGAL (2)
- ITGAX (2)
- KRT13 (2)
- KRT7 (2)
- LEY (2)
- LMNA (2)
- MMP1 (2)
- MMP3 (2)
- MSLN (2)
- MUC1 (2)
- MYOG (2)
- N (2)
- NCAM1 (2)
- NOTCH2 (2)
- PDCD6IP (2)
- PECAM1 (2)
- PLK1 (2)
- POU2F2 (2)
- PXN (2)
- RPS27A (2)
- S100A6 (2)
- SLC3A2 (2)
- TAG72 (2)
- TCL1A (2)
- TIGAR (2)
- TIMD4 (2)
- TNFRSF8 (2)
- TNFSF11 (2)
- TP53 (2)
- TRAF2 (2)
Reactivities
- Human (523)
- Mouse (177)
- Rat (108)
- Bovine (18)
- Primate (15)
- Monkey (13)
- Porcine (8)
- Rabbit (8)
- Chicken (7)
- Canine (6)
- Sheep (5)
- Zebrafish (5)
- Avian (4)
- Frog (4)
- Guinea Pig (4)
- Hamster (4)
- Mammalian (4)
- Xenopus (4)
- Chimpanzee (3)
- Cow (3)
- Dog (3)
- Drosophila (3)
- Yeast (3)
- Equine (2)
- Feline (2)
- Goat (2)
- Pig (2)
- SARS-CoV (2)
- All Species (1)
- Baboon (1)
- C. elegans (1)
- Cynomolgus (1)
- Ferret (1)
- Fruit fly (1)
- Macaque (1)
- Marmoset (1)
- Plant (1)
- Respiratory Syncytial Virus (1)
- Virus (1)
Applications
Antibody Hosts
Clonalities
Conjugates
Modifications
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (11)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (6)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (6)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. (3)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric human antibody, based on the original mouse IgG2a format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original hamster IgG format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- This is a reformatted mouse IgG1 antibody, based on the original mouse IgG2a format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (252)
- Transmembrane (122)
- Protein Kinase (58)
- Transcription Factors (45)
- ES Cell Differentiation/IPS (34)
- Secreted Protein (29)
- Protease (24)
- Stem cell - Pluripotency (22)
- P450 (13)
- Adult stem cells (10)
- Phosphatase (5)
- Cancer stem cells (3)
- Embryonic stem cells (3)
- Induced pluripotent stem cells (3)
- Stem cell relevant signaling - JAK/STAT signaling pathway (3)
- GPCR (2)
- Ion Channels: Other (2)
- Nuclear Hormone Receptor (2)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (2)
- Stem cell relevant signaling - Wnt Signaling pathway (2)
- Stem cell relevant signaling - DSL/Notch pathway (1)
Pathways
- Pathways in cancer (88)
- Prostate cancer (62)
- Bladder cancer (57)
- Pancreatic cancer (55)
- Endometrial cancer (51)
- Focal adhesion (50)
- Non-small cell lung cancer (47)
- ErbB signaling pathway (46)
- Adherens junction (45)
- Calcium signaling pathway (41)
- Apoptosis (26)
- Metabolic pathways (22)
- Neurotrophin signaling pathway (22)
- Small cell lung cancer (21)
- B cell receptor signaling pathway (20)
- T cell receptor signaling pathway (20)
- MAPK signaling pathway (19)
- Colorectal cancer (18)
- Chemokine signaling pathway (17)
- Chronic myeloid leukemia (17)
- Cell adhesion molecules (CAMs) (16)
- Amyotrophic lateral sclerosis (ALS) (15)
- NOD-like receptor signaling pathway (15)
- Toll-like receptor signaling pathway (15)
- p53 signaling pathway (15)
- Cytokine-cytokine receptor interaction (14)
- Adipocytokine signaling pathway (13)
- Cell cycle (13)
- Huntington's disease (13)
- RIG-I-like receptor signaling pathway (13)
- Acute myeloid leukemia (12)
- Cytosolic DNA-sensing pathway (12)
- Alzheimer's disease (11)
- Epithelial cell signaling in Helicobacter pylori infection (11)
- Retinol metabolism (11)
- Fc gamma R-mediated phagocytosis (9)
- Natural killer cell mediated cytotoxicity (9)
- Insulin signaling pathway (8)
- Leukocyte transendothelial migration (8)
- Regulation of actin cytoskeleton (8)
- Complement and coagulation cascades (7)
- Jak-STAT signaling pathway (7)
- Melanoma (7)
- Cysteine and methionine metabolism (6)
- Drug metabolism - cytochrome P450 (6)
- Endocytosis (6)
- Glioma (6)
- GnRH signaling pathway (6)
- Hematopoietic cell lineage (6)
- Lysosome (6)
- Oocyte meiosis (6)
- PPAR signaling pathway (6)
- Primary immunodeficiency (6)
- Progesterone-mediated oocyte maturation (6)
- Renal cell carcinoma (6)
- Thyroid cancer (6)
- Viral myocarditis (6)
- Wnt signaling pathway (6)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (5)
- Dilated cardiomyopathy (5)
- Drug metabolism - other enzymes (5)
- Fc epsilon RI signaling pathway (5)
- Hypertrophic cardiomyopathy (HCM) (5)
- Metabolism of xenobiotics by cytochrome P450 (5)
- Prion diseases (5)
- VEGF signaling pathway (5)
- mTOR signaling pathway (5)
- Gap junction (4)
- Linoleic acid metabolism (4)
- Parkinson's disease (4)
- Systemic lupus erythematosus (4)
- TGF-beta signaling pathway (4)
- Vascular smooth muscle contraction (4)
- Basal cell carcinoma (3)
- Caffeine metabolism (3)
- Dorso-ventral axis formation (3)
- ECM-receptor interaction (3)
- Glycolysis / Gluconeogenesis (3)
- Long-term potentiation (3)
- Melanogenesis (3)
- Notch signaling pathway (3)
- Pathogenic Escherichia coli infection (3)
- Tight junction (3)
- Antigen processing and presentation (2)
- Axon guidance (2)
- Homologous recombination (2)
- Long-term depression (2)
- Porphyrin and chlorophyll metabolism (2)
- RNA degradation (2)
- Ribosome (2)
- Spliceosome (2)
- Tryptophan metabolism (2)
- Type II diabetes mellitus (2)
- Aminoacyl-tRNA biosynthesis (1)
- Arachidonic acid metabolism (1)
- Base excision repair (1)
- Cardiac muscle contraction (1)
- Fatty acid metabolism (1)
- One carbon pool by folate (1)
- Oxidative phosphorylation (1)
- Purine metabolism (1)
- Pyruvate metabolism (1)
- Regulation of autophagy (1)
- Starch and sucrose metabolism (1)
- Steroid biosynthesis (1)